Matthew Ronsheim

Affiliations

  • See Remarks at Innoviva Inc. (INVA), 2024-05-22
  • Chief Of Pharma Sciences & Mfg at Entasis Therapeutics Holdings Inc. (ETTX), 2022-07-11
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ETTX $3.19 3,759 Officer 46,241 2021-10-19 Filing